(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

DOSAGEM DE FEDRATINIBE

ArquivadaInvention PatentPCT · US2021063563

Application data

Number

112023010084

Type

Invention Patent

Filing

12/15/2021

Publication

06/27/2023

PCT

US2021063563

Progress at the INPI

  1. Filing12/15/21
  2. Publication06/27/23
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 12/15/2021 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 03/11/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

IMPACT BIOMEDICINES, INC.

US

See this company's full portfolio

Inventors

G. K. (pessoa física)

US

K. O. (pessoa física)

US

Technical data

Priority claims

US

63/126,289 · 12/16/2020

Abstract

DOSAGEM DE FEDRATINIBE.A presente invenção refere-se a métodos de tratamento de distúrbios mieloproliferativos em pacientes recebendo simultaneamente um inibidor dual de CYP2C19 e CYP3A4.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

03/11/2025

RPI 2827

Arquivamento - Art. 33 da LPI

#11.1

12/24/2024

RPI 2816

Notificação de entrada na fase nacional - PCT

#1.3

06/27/2023

RPI 2738

Alteração de dados cadastrais

#1.1

06/06/2023

RPI 2735

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.